Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells  by Semenchuk, Lori A. & Di Salvo, Joseph
FEBS 15880 FEBS Letters 370 (1995) 127 130 
Receptor-activated increases in intracellular calcium and protein tyrosine 
phosphorylation in vascular smooth muscle cells 
Lori A. Semenchuk, Joseph Di Salvo* 
Department qf Medical and Molecular Physiology, School of Medicine, University of Minnesota-Duluth, 10 University Drive, Duluth, MN 55812, USA 
Received 14 June 1995 
Abstract We studied the effects of protein tyrosine kinase inhib- 
itors (genistein and tyrphostin) on receptor-activated increases in 
cellular Ca 2+ ([Ca2+]i), and protein tyrosine phosphorylation in 
cultured canine femoral arterial smooth muscle cells. Fura-2 im- 
aging analysis showed that each agonist evoked a transient in- 
crease in ([Ca2+]i) followed by a sustained plateau phase. Exper- 
iments in Ca2+-free medium showed that 70-80% of the transient 
increase in [Ca2+]i evoked by either agonist is due to influx of 
extracellular Ca 2+ whereas the plateau phase is only due to Ca 2+ 
entry. Pre-incubation with genistein or tyrphostin markedly 
inhibited the transient rise in [Ca2+]j evoked by serotonin or 
phenylephrine. Immunoblot analysis of cell extracts with anti- 
phosphotyrosine antibodies revealed that serotonin and 
phenylephrine also evoked an increase in tyrosine phosphoryla- 
tion of several substrates. These increases were abolished by 
tyrosine kinase inhibitors. One of the major substrates was recog- 
nized by an antibody for rasGAP. These data suggest hat recep- 
tor-activated increases in [Ca2+]i in vascular smooth muscle cells 
may be coupled to receptor-activated increases in protein tyrosine 
phosphorylation. 
To more directly test the hypothesis that a functional ink 
exists between receptor-activated increases in [Ca2÷], and pro- 
tein tyrosine phosphorylation i smooth muscle cells, we stud- 
ied interrelationships among receptor-activation f cultured 
VSMC, increases in [Ca-~+]~, and enhanced protein tyrosine 
phosphorylation. We report that increases in [Ca2+]~ evoked by 
stimulation of ~-adrenergic receptors with phenylephrine or 
serotoninergic receptors with serotonin are associated with en- 
hanced protein tyrosine phosphorylation of several substrates. 
One of the substrates is rasGAP, the GTPase Activating Pro- 
tein for the small G-protein called ras. We also report that 
genistein, a potent inhibitor of tyrosine kinases [10] reversibly 
inhibits receptor-activated increases in [Ca2+]~ and enhanced 
tyrosine phosphorylation of rasGAP. These observations sug- 
gest that a signaling pathway for increasing [Ca2+]i n VSMC 
probably involves receptor activation, enhanced tyrosine phos- 
phorylation of rasGAP and the participation of a small 
G-protein such as ras. 
Key words: Ca z+ influx; Ca 2+ release; Tyrosine kinase inhibitor; 
Protein tyrosine phosphorylation; Ratiometric fluorescence 
analysis; rasGAP; Vascular smooth muscle cell 
I. Introduction 
Since the intracellular concentration of Ca 2+ ([Ca2+]i) is a 
major determinant of contractile force, much effort has been 
devoted to elucidating mechanisms which regulate [CaZ+]~ in 
smooth muscle [1,2]. It is now clear that multiple and complex 
signaling pathways participate in these mechanisms. Recently, 
we suggested that phosphorylation of proteins on tyrosine res- 
idues may be an important mechanism for regulating [Ca2+]~ in 
vascular smooth muscle cells (VSMC; [3-5]). This hypothesis 
is based on evidence showing that: (a) tyrosine kinase activity, 
such as that due to the proto-oncogene product, pp60C-src, is 500- 
to 700-fold greater in extracts from smooth muscle that in 
extracts from cardiac or skeletal muscle [6,7]; (b) structurally 
diverse inhibitors of tyrosine kinase activity such as genistein 
and synthetic tyrphostins inhibit receptor-activated contraction 
of vascular and visceral smooth muscle [4,5,8,9]; and (c) vana- 
date, a known contractile agent which also inhibits protein 
tyrosine phosphatase activity, induces contraction of visceral 
smooth muscle that is dependent on extracellular Ca 2÷ and is 
associated with enhanced protein tyrosine phosphorylation of 
several substrates [8]. 
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2. Materials and methods 
2.1. Cell culture 
Experiments were performed with VSMC cultures from canine fem- 
oral arteries using methods adapted from Seidel et al. [11] and Thy- 
berg's laboratory [12]. Cells were seeded in T-25 cm 2 flasks and incu- 
bated at 37°C in humidified air and 5% CO2. Growth medium (DMEM, 
pH 7.4, 10 mM MES, 10 mM TES, 10% fetal calf serum, 1 mM 
glutamine, 50 mg/ml ascorbic acid, and antibiotics) was changed every 
third day and cells were passaged 1:3 when confluent. Each culture was 
from a single animal. Only passages 2-4 were used for experiments. 
2.2. Measurement of intracellular Ca :+ with fura-2 [13,14] 
Cells were grown on 22 mm coverslips for 2448 h, serum deprived 
for 24 h, then incubated with 4 mM fura-2/AM for 1 h at room temper- 
ature, rinsed, and incubated with serum-free DMEM for 30 min to 
permit intracellular esterases to cleave fura-2/AM to fura-2. They were 
rinsed with physiological salt solution (PSS) and placed in a Bellco 
chamber at room temperature. PSS contained (in mM): NaCI, 140; 
KC1, 5; CaC12, 1.6, MgC12, 1.2; Na2HPO4, 1.2; and glucose, 5.6 (pH was 
adjusted to 7.54). Agonist induced increases in [Ca2÷]~, evidenced by an 
increase in 340/380 fluorescence ratio, were monitored using a Nikon 
Diaphot TMD microscope and an Image-1 analysis ystem. Cells were 
excited at 340 nm and 380 nm and relative fluorescence was measured 
at 510 nm. We used changes in the 340/380 fluorescence ratio as an 
index of changes in [Ca2+]~ rather than routinely converting ratios into 
absolute [Ca2+]. However, in situ calibrations in 16 cells showed that 
a ratio of 1 corresponds to 140 nM Ca 2÷ and a ratio of 3 corresponds 
to 965 nM, values which agree with reported levels for resting and 
stimulated [Ca:+]~ [13,14]. 
2.3. Determination of protein tyrosine phosphorylation 
Parallel cell cultures were treated with serotonin or phenylephrine for 
0-60 sec, and lysed in buffer containing 0.5% SDS, 5 mM EDTA, 1.5 
mM sodium ortho-vanadate, 20 mM Tris, 150 mM NaCI, 100 nM 
okadaic acid, and a mixture of protease inhibitors. Lysates were heated 
at 95°C/5 min, centrifuged 5 min at 15,000 rpm, and supernatant pro- 
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tein was adjusted to 1 mg protein/ml. Proteins were separated by SDS 
gel electrophoresis (4-15% gradient, I0 ,ug protein/lane), and electro- 
phoretically transferred to nitrocellulose membranes. Non-specific 
binding sites were blocked by incubating inTris-buffered saline + 0.5% 
Tween 20 (TBST) containing 2% bovine serum albumin (BSA) for 4 h 
at room temperature. Tyrosine phosphorylated proteins were detected 
with a monoclonal nti-phosphotyrosine antibody (UBI) diluted 1 : 5000 
(0.2 pg/ml) in TBST + 2% BSA overnight at 4°C. The membranes were 
incubated with horseradish peroxidase conjugated anti-mouse antibody 
(Amersham), and washed in 5 changes of TBST. Substrates were visu- 
alized with chemiluminescense reagents (Amersham), exposure to 
autoradiographic film, and quantitative d nsitometry. In several experi- 
ments, membranes were stripped of phosphotyrosine antibody, and 
then probed with a polyclonal antibody for rasGAP (GTPase Acti- 
vating Protein, UBI). 
3. Results 
3.1. Effects of serotonin and phenylephrine on [Ca2+]i in the 
presence and absence of tyrosine kinase inhibitors 
Stimulation of femoral arterial VSMC with serotonin or 
phenylephrine evoked a pronounced transient increase in 
[Ca2+]~ (Fig. 1). That is, stimulation with 100 nM serotonin 
resulted in a rapid 6.6-fold increase in the 340/380 ratio which 
then declined to a sustained level of 1.7-fold (Fig. 1A). Simi- 
larly, 100 pM phenylephrine produced a rapid 2.7-fold increase 
in the ratio which declined to a sustained level of about 1.4-fold 
(Fig. 1B). To determine the extent o which the transient and 
sustained increases in [Ca2+]~ were dependent on extracellular 
Ca 2+, responses were elicited in Ca2+-free medium containing 
0.5 mM EGTA. Stimulation of 104 cells with 100 nM serotonin 
in normal Ca2+-containing PSS increased the 340/380 ratio 
from a basal ratio of 0.61 + 0.03 to a maximal value of 5.11 + 
0.69, which then declined to a sustained level of 1.02 + 0.09. 
However, after incubation i  Ca2+-free PSS containing EGTA 
for 5 min, the maximal increase in the ratio evoked by serotonin 
was only 1.76 + 0.19 (P < 0.005 relative to control) and the 
sustained phase was virtually abolished. Therefore, about 80% 
of the early transient response was dependent on extracellular 
Ca 2+, whereas essentially all of the later sustained response was 
dependent on extracellular Ca 2+. Similar results were obtained 
with phenylephrine. 
Pre-incubation with 110 pM genistein for 45 min virtually 
abolished the transient rise in [Ca2+]i evoked by serotonin or 
phenylephrine. Genistein also inhibited the later sustained re- 
sponse to phenylephrine, but it did not alter the sustained 
response to serotonin. Tyrphostin, a synthetic tyrosine kinase 
inhibitor that is structurally different from genistein and has a 
different mechanism ofaction [15], also inhibited the serotonin- 
activated Ca 2÷ transient. Before incubation with 80 pM tyr- 
phostin (70 cells), 100 nM serotonin increased the 340/380 ratio 
from its basal value (0.47 + 0.08) to a maximal value of 2.53 + 
0.72 (P = 0.002). However, incubation with tyrphostin for 45 
min inhibited the response by 28.8% (P = 0.012), while incuba- 
tion with tyrphostin for 2 h inhibited the response by 87.5% 
(P = O.OO7). 
3.2. Effects of serotonin, phenylephrine, and tyrosine kinase 
inhibitors on protein tyrosine phosphorylation i VSMC 
Stimulation with 100 nM serotonin (Fig. 2A) or 100 pM 
phenylephrine (Fig. 3A) induced a rapid transient increase in 
protein tyrosine phosphorylation f a similar set of substrates. 
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Fig. 1. Receptor-activated changes in [Ca2+]~ (340/380 fluorescence 
ratio; see section 2) in canine VSMC loaded with fura-2. Stimulation 
with either 100 nM serotonin (Panel A, 159 cells) or 100/,tM phenyl- 
ephrine (Panel B, 67 cells ) produced arapid transient increase in the 
340/380 fluorescence ratio (159 cells). Pre-incubation with genistein 
(110 pM, 45 min) markedly reduced the transient response evoked by 
serotonin (67 cells) or phenylephrine (42 cells). However, the later 
sustained phase voked by serotonin was unaffected by pre-incubation 
with genistein, whereas genistein completely abolished the later sus- 
tained phase voked by phenylephrine. Complete recovery of respon- 
siveness to phenylephrine occurred when cells were bathed in genistein- 
free PSS for 45 min. Recovery of responsiveness to erotonin, though 
apparent after 45 min in genistein-free PSS, was not complete until after 
2 h without genistein. Blockade of serotonergic receptors with 100 nM 
methysergide (23cells) eliminated responses to serotonin, and blockade 
of ~t-adrenergic re eptors with 100 pM prazosin (18 cells) eliminated 
responses tophenylephrine. 
Pre-incubation with 110 BM genistein or 80 pM tyrphostin, the 
same concentrations which inhibited receptor-activated in-
creases in [Ca2+]i (Fig. 1), inhibited receptor-activated increases 
in protein tyrosine phosphorylation (Fig. 2). 
We suspected that the tyrosine-phosphorylated substrate of 
116 kDa might be rasGAP, a known tyrosine-phosphorylated 
substrate of 116 120 kDa which participates in diverse signal- 
ing pathways [16,17]. Accordingly, nitrocellulose membranes 
which were immunoblotted for phosphotyrosine proteins were 
stripped of antibody and reprobed with a polyclonal antibody 
for rasGAP (Fig. 3B). The single band recognized by the 
rasGAP specific antibody was coincident with the tyrosine 
phosphorylated substrate of 116 kDa. None of the other tyro- 
sine-phosphorylated substrates were recognized by the rasGAP 
antibody. Moreover, when cellular extracts were immunopre- 
cipitated with rasGAP antibody before electrophoresis, the 116 
kDa tyrosine phosphorylated substrate was recovered in the 
precipitate (not shown). 
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Fig. 2. Activation of ~radrenergic receptors in VSMC with phenyl- 
ephrine nhances protein tyrosine phosphorylation:receptor-activated ty- 
rosine phosphorylation that is suppressed bytyrosine kinase inhibitors. 
Cells were xposed to 100 pM phenylephrine for0-60 sec and processed 
for immunoblot analysis of changes in protein tyrosine phosphoryla- 
tion. A pronounced transient increase in tyrosine phosphorylation was 
apparent for a major substrate of 116 kDa and several other polypep- 
tides. The increase in tyrosine phosphorylation bserved after 15 s 
exposure to phenylephrine (PE) was markedly inhibited in cells which 
had been pre-incubated with 110,uM genistein or 80 pM tyrphostin for 
45 min. Similar esults were obtained in 4 experiments. 
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4.  D iscuss ion  
The major point of this study is that receptor-activated in- 
creases in [Ca2+]i in cultured VSMC may be coupled to recep- 
tor-activated increases in protein tyrosine phosphorylation. 
This conclusion is supported by our observations showing that: 
(a) stimulation of ~-l-adrenergic or serotonergic receptors re- 
sults in a transient increase in [Ca2+]i (Fig. 1); (b) receptor- 
activation also enhances tyrosine phosphorylation f the same 
or similar set of substrates (Figs. 2 and 3); and (c) both the 
increase in [Ca2+]~ and the increase in protein tyrosine phospho- 
rylation are inhibited by compounds which inhibit tyrosine 
kinase activity. The differential effect of tyrosine kinase inhib- 
itors on the delayed sustained Ca 2+ response to serotonin and 
phenylephrine may reflect differences between Ca 2+ influx path- 
ways activated by different vasoactive agents [1,2,18]. In con- 
trast, the consistent inhibition of transient increases in [Ca2+]~ 
evoked by serotonin or phenylephrine suggest hat both the 
influx and release components of the transient are modulated 
by tyrosine phosphorylation. 
Previous tudies howed that stimulation of cultured rat aor- 
tic smooth muscle cells with vasoactive agents increased tyro- 
sine phosphorylation f several substrates [19,20]. The pattern 
of protein tyrosine phosphorylation bserved in this study was 
remarkably similar to that observed in the earlier studies. 
Our data also indicate that one of the major tyrosine 
phosphorylated substrates, a polypeptide of 116 kDa is 
rasGAP.  However, Molloy et al. did not observe changes in 
tyrosine phosphorylation f rasGAP during receptor-activa- 
tion of rat aortic smooth muscle cells [20]. This disparity may 
reflect procedural differences. We used canine femoral VSMC 
stimulated with serotonin or phenylephrine, and single label 
immunoblot technology for assessing changes in phosphoryla- 
tion of rasGAP.  Molloy et al. [20] studied rat aortic cells stim- 
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Fig. 3. Activation of serotoninergic re eptors evokes tyrosine phospho- 
rylation of rasGAP (rasGTPase Activating Protein). (Panel A) Cells 
were stimulated with 100 nM serotonin and processed for immunoblot 
analysis (Western blot) of tyrosine phosphorylated substrates a in Fig. 
2. Note that the set of substrates phosphorylated in response to sero- 
tonin is similar to the substrates phosphorylated in response tophenyle- 
phrine shown in Fig. 2. (Panel B) The immunoblotted nitrocellulose 
membrane photographed in Panel A was stripped of phosphotyrosine 
antibody and probed with a polyclonal ntibody for rasGAP. Only the 
116 kDa substrate was recognized by the rasGAP antibody. Similar 
results were obtained in 6 experiments. 
ulated with angiotensin II, and used immunoprecipitation tech- 
nology for assessing changes in phosphorylation f rasGAP.  
rasGAP is known to physically associate with the tyrosine 
kinase pp60 ..... . Tyrosine phosphorylation f rasGAP appears 
to decrease its ability to enhance the GTPase activity of its 
target, ras [16,17]. Therefore, ras is maintained in its activated 
GTP-bound state. Moreover, ras stimulates Ca 2+ channels in 
neuronal cells [21]. Since pp60 ..... [6,7], ras [22], and rasGAP 
are present in VSMC (Fig. 3B), it is tempting to speculate that 
they may participate in a signalling pathway which modulates 
receptor-activated increases in [Ca2+]i required for smooth mus- 
cle contraction. An attractive feature of this hypothesis that 
it is testable. In accordance with results from other laboratories 
(reviewed in [1,2,18], the initial Ca 2+ transient evoked by either 
phenylephrine or serotonin is due to both (a) influx of Ca 2÷ 
which is evident in the presence of extracellular Ca 2+, and (b) 
release of intracellular Ca 2÷ which is evident in the absence of 
extracellular Ca 2+ (see section 3). As noted earlier, tyrosine 
phosphorylation probably participates in both the influx and 
release components ofthe Ca -'+ transient because both genistein 
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and tyrphostin markedly suppress phosphorylation and virtu- 
ally abolish the Ca 2÷ transient. However, it is likely that mech- 
anisms in addition to protein tyrosine phosphorylation partici- 
pate in modulation of receptor-activated increases in [Ca2+]i in 
VSMC [1,5,18]. It is also possible that that the inhibitory effects 
of genistein and tyrphostin involve mechanisms in addition to 
inhibition of tyrosine kinase activity. 
In summary, the new evidence reported in this study 
(Figs. l -3) strongly suggests that receptor-activation f VSMC 
enhances tyrosine phosphorylation of several substrates, in- 
cluding rasGAP, and that such phosphorylation may be cou- 
pled to receptor-activated increases in [Ca2+]i . Future studies 
aimed at elucidating underlying mechanisms which may couple 
receptor- activated increases in protein tyrosine phosphoryla- 
tion and increases in [Ca>]i promise to enhance our under- 
standing of how smooth muscle function is regulated. 
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